Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans: The significance of insulin secretion, insulin sensitivity, and glucose effectiveness

Diabetes Care

Volumn 20, Issue 3, 1997, Pages 396-404

  Osei, Kwame ^a,b   Gaillard, Trudy ^a   Schuster, Dara P ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b 485 McCampbell Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR CLINICAL STUDY; MALE; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PATHOGENESIS;

EID: 0031029345     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.3.396     Document Type: Article

References (49)

1. DeFronzo RA, Ferrannini E, Simonson DC: Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387-395, 1989
2. Reaven GM, Bernstein R, Davis B, Olefsky JM: Nonketotic diabetes mellitus: insulin deficiency or insulin resistance. Am J Med 60:80-88, 1976
3. Harris MI, Hadden WC, Knowler WC, Bennett PH: 1987 prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74. Diabetes 36:523-524, 1987
4. King H, Rewers M: Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 16:157-177, 1993
5. Dowse GK, Zimmet PZ, Alberti KGMM, Brigham L, Carlin JB, Tuomilehto J, Knight LT, Garebo H, Mauritius NCD Study Group: Serum insulin distribution and reproducibility of the relationship between 2-hr insulin and plasma glucose levels in Asian, Indian, Creole, and Chinese Mauritians. Diabetes 42:1232-1241, 1993
6. Sicree RA, Zimmet PZ, King HOM, Coventry JS: Plasma insulin in Nauruans: prediction of deterioration in glucose tolerance over 6 years. Diabetes 36:179-186, 1987
7. Fujimoto WY, Leonotti DL, Kinyoun JL: Prevalence of diabetes mellitus and impaired glucose tolerance among second generation Japanese-American men. Diabetes 36:721-729, 1987
8. Bennett PH, Burch TA, Miller M: The high prevalence of diabetes in the Pima Indians of Arizona (USA). Amsterdam, Excerpta Med., 1980, p. 33-39 (Int. Congr. Ser., no. 221)
9. Haffner SM, Stern MP, Mitchell BD, Hazuda HP, Patterson JK: Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body fat distribution. Diabetes 39:281-288, 1990
10. Osei K, Cottrell DA: Minimal model analyses of insulin sensitivity and glucose dependent glucose disposal in black and white Americans: a study of persons at risk for type II diabetes. Eur J Clin Inv 24:843-850, 1994
11. Osei K, Cottrell DA, Harris B: Differences in basal and post-stimulation glucose homeostasis in nondiabetic first degree relatives of black and white patients with type II diabetes mellitus. J Clin Endocrinol Metab 75:82-86, 1992
12. Osei K, Schuster DP: Ethnic differences in secretion, sensitivity and hepatic extraction of insulin in black and white Americans. Diabet Med 11:755-762, 1994
13. Haffner SM, D'Agostino R, Saad MF, Rewers M, Mykinen L, Selby J, Howard G, Savage PJ, Hamman RF, Wagenknecht LE, Bergman RN: Increased insulin resistance and insulin secretion in nondiabetic African Americans and Hispanics compared with non-Hispanic whites: The Insulin Resistance Atherosclerosis Study. Diabetes 45:742-748, 1996
14. Haffner S, Howard G, Savage P, Mayer B, Rewers M: African Americans are not more insulin sensitive than Hispanics or non-Hispanic whites with NIDDM (Abstract). Diabetes 45 (Suppl. 2):135A, 1996
15. Freedman DS, Srinivasan SS, Burke GL, Shear L, Smoak CG, Harsha DW, Weber LS, Berenson GS: Relation of body fat distribution to hyperinsulinemia in children and adolescents: The Bogalusa Heart Study. Am J Clin Nutr 46:403-410, 1987
16. Svec F, Nastasi K, Hilton C, Bao W, Srinivasan SR, Berenson SR: Black-white contrast in insulin levels during pubertal development: The Bogalusa Heart Study. Diabetes 41:314-317, 1992
17. Dowling HJ, Pi-Sunyer FX: Race-dependent health risks of upper body obesity. Diabetes 42:537-543, 1993
18. Banergi MA, Lebovitz HE: Insulin sensitive and insulin insensitive variants of NIDDM. Diabetes 38:784-792, 1989
19. Taniguchi A, Nakai Y, Fukushima M, Imura H, Kawamura H, Nagato H, Florant GL, Tokuyama K: Insulin sensitivity and insulin secretion in subjects with impaired glucose tolerance: a minimal model analysis. Metabolism 43:714-718, 1994
20. Taniguchi A, Nakai Y, Fukushima M, Imura H, Kawamura H, Nagato H, Florant GL, Tokuyama K: Pathogenic factors responsible for glucose intolerance in patients with NIDDM. Diabetes 41:1540-1546, 1992
21. Taniguchi A, Nakai Y, Doi K, Fukuzawa H, Fukushima M, Kawamura H, Tokuyama K, Suzuki M, Fujitani J, Tanaka H, Nagata I: Insulin sensitivity, insulin secretion and glucose effectiveness in obese subjects: a minimal model analysis. Metabolism 44:1397-1400, 1995
22. Welch NS, Gebhart SP, Bergman RN, Phillips LS: Minimal model IVGTT-derived insulin sensitivity in diabetics. J Clin Endocrinol Metab 71:1508-1518, 1990
23. Bergman RN: Toward physiological understanding of glucose tolerance: minimal model approach. Diabetes 38:1512-1527, 1989
24. Kautzky-Miller A, Pacini G, Ludvik B, Schernthaner G, Prager R: Beta-cell hyper-secretion and not reduced hepatic insulin extraction is the main cause of hyperinsulinemia in obese nondiabetic subjects. Metabolism 41:1304-1312, 1992
25. Osei K, Schuster DP: Decreased insulin-mediated but not non-insulin dependent glucose disposal in glucose intolerance and type II diabetes in African (Ghanaian) immigrants. Am J Med Sci 311:113-121, 1996
26. Martin BC, Warram JH, Krowleski AS, Bergman RW, Soeldner JS, Kahn CR: Role of glucose and insulin resistance in development of type II diabetes mellitus: results of a follow-up study. Lancet 340:925-929, 1992
27. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
28. Lukaski HC, Bolonchuk WW, Hall CV, Siders WA: Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol 60:1327-1332, 1986
29. Gray DS, Gray GA, Gemayel N, Kaplan KI: Effect of obesity on bioelectrical impedance. Am J Clin Nutr 50:255-260, 1989
30. Segal KR, Loan MC, Fitzgerald PL, Hodgdon JA, Van Itallie TB: Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study. Am J Clin Nutr 47:4-17, 1988
31. Bergman RN, Prager R, Volund A, Olefsky J: Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 79:790-800, 1987
32. Kahn SE, Prager RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward JC, Palmer JP, Porte D Jr: The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects. Diabetes 43:587-592, 1993
33. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Bergman RN, Schwartz MM, Neifing WK, Beard JC, Palmer JP, Porte D Jr: Quantification of the relationship between insulin sensitivity and beta cell function in humans: evidence for hyperbolic function. Diabetes 32:1663-1672, 1993
34. Lipton RB, Liao Y, Cao G, Cooper RS, McGee D: Determinants of incident non-insulin-dependent diabetes among blacks and whites in a national study: the NHANES I epidemiologic follow-up. Am J Epidemiol 138:826-839, 1993
35. Phillips DIW, Clark PM, Hale CN, Osmond C: Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin and insulin secretion. Diabetes 11:286-292, 1994
36. Chen K-W, Boyko EJ, Bergston RW, Leonetti D, Newell-Morris L, Wahl PA, Fujimoto WY: Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM: 5-year follow-up of initially nondiabetic Japanese-American men. Diabetes Care 18:747-753, 1995
37. Motalal M, Omar MAK: Evidence for impaired pancreatic beta cell function in southern African Indians with impaired glucose tolerance. Diabet Med 11:437-444, 1994
38. Davis MJ, Metcalfe J, Gray IP, Day JL, Hale CN: Insulin deficiency rather than hyperinsulinemia in newly diagnosed type II mellitus. Diabet Med 10:305-312, 1993
39. Davies MJ, Rayman G, Grentell A, Gray IP, Hale CN: Loss of the first phase response to intravenous glucose in subjects with persistent impaired glucose tolerance. Diabet Med 11:432-436, 1994
40. O'Rahilly SP, Rudenski AS, Burnett MA, Nugent Z, Hosker JP, Darling P: Beta cell dysfunction rather than insulin sensitivity is the primary defect in familial type 2 diabetes. Lancet ii:3660-3663, 1986
41. Lundgren H, Bengston C, Blohme G, Lapidus L, Waldenstom J: Fasting serum insulin concentration and early insulin response as risk determinants for developing diabetes. Diabetes 7:407-413, 1990
42. Vaag A, Henrikson JE, Madsbad S, Holm N, Beck-Nelson O: Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin dependent mellitus. J Clin Invest 95:690-698, 1995
43. Watanabe R, Laws A, Rewers M, Bergman RN: Impaired glucose tolerant subjects exhibit a β-cell defect despite normal fasting glycemia (Abstract). Diabetes 44 (Suppl. 1):4A, 1995
44. Conway JM, Yanosky SZ, Hubbard VS: Visceral adipose tissue differences in black and white women. Am J Clin Nutr, 61:765-769, 1995
45. Tokuyama K, Higaki Y, Fujitani J, Taniguchi A, Nakai Y, Doi K, Fukuzawa H, Fukushima M, Kawamura HT, Suzuki M, FujitaniJ, Tanaka H, Nagata I: Intravenous glucose tolerance test-derived glucose effectiveness in physically trained humans. Am J Physiol 265: E298-303, 1993
46. Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen Y-DI, Sands RE, Pei D, Savage PJ, Bergman RN: A comparison between the minimal model and glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance: The Insulin Resistance Atherosclerosis Study. Diabetes 43:1114-1121, 1994
47. Best JD, Kahn SE, Ader M, Watanabe RM, Ta-Ghen N, Bergman RN: Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care 19:1018-1030, 1996
48. Nolan JJ, Ludvik B, Berdsen RN, Joyce M, Olefsky J: Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 331:1188-1193, 1994
49. Berkowitz K, Peters R, Kjos S, Goico J, Marquin M, Dunn S, Buchanan T: Effect of troglitazone on insulin sensitivity and secretion in women with prior gestational diabetes (Abstract). Clin Sci 44:112A, 1996